Temporary ICUs during the COVID-19 pandemic first wave: description of the cohort at a French centreArticle Published on 2022-10-032023-07-10 Journal: BMC Anesthesiology [Category] COVID19(2023년), [키워드] ARDS COVID-19 intensive care sanitary crisis Temporary ICU. [DOI] 10.1186/s12871-022-01845-9 PMC 바로가기
Ursolic acid and SARS-CoV-2 infection: a new horizon and perspectiveArticle Published on 2022-10-012022-11-15 Journal: Inflammopharmacology [Category] COVID19(2023년), SARS, 치료제, [키워드] acute lung injury acute respiratory distress acute respiratory syndrome Anti-inflammatory anti-inflammatory cytokines antioxidant antioxidant effects Antiviral ARDS Complication complications coronavirus COVID-19 Cytokine storm disease-causing disorders dysregulation hyper inflammation immune response Immunity IMPROVE indirect effect inflammatory signaling inhibit lung manifestation mitigate neurological oxidative stress pandemic Pandemics Pathways Perspective pro-inflammatory cytokine pro-inflammatory cytokines progression RAS reactive oxygen specy reduce renin-angiotensin system ROS SARS-CoV-2 SARS-COV-2 infection severe cases syndrome ursolic acid Viral pneumonia [DOI] 10.1007/s10787-022-01038-3 PMC 바로가기
Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 InfectionArticle Published on 2022-10-012023-07-07 Journal: The Annals of Pharmacotherapy [Category] COVID19(2023년), [키워드] ARDS Epoprostenol Inhaled prostacyclin pulmonary vasodilator. SARS-CoV-2 [DOI] 10.1177/10600280211069182
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysisResearch article Published on 2022-10-012022-10-05 Journal: Seminars in arthritis and rheumatism [Category] 변종, [키워드] 1:1 Acute kidney injury acute respiratory distress adjust African American AKI Analysis ARDS association Black race Cancer patients cohort analysis confounders Control controls COVID-19 database dermatomyositis determine develop Disease activity drug Gender General population glucocorticoid heterogeneous nature High dose higher odd hospitalisation ICU admission identify ILD Immunosuppressant immunosuppressive individual Infection Interstitial lung disease lower risk male mechanical ventilation Mortality neoplasm Neoplasms outcome outcomes Patient patients with COVID-19 Precaution receiving renal replacement therapy required retrieved retrospective data rheumatic disease risk RRT score Sepsis severe COVID-19 Severe COVID-19 Infection severity of COVID-19 stroke subgroup analysis syndrome therapy Treatment Venous Thromboembolism VTE was used with COVID-19 [DOI] 10.1016/j.semarthrit.2022.152034 [Article Type] Research article
ARDS in the time of corona: context and perspectiveArticle Published on 2022-10-012022-11-16 Journal: American journal of physiology. Lung cellular and [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory distress ARDS COVID-19 disease endothelial infections mutants Perspective Respiratory failure severe COVID-19 syndrome therapeutic therapy to define Treatment Ventilator-induced lung injury [DOI] 10.1152/ajplung.00432.2021 PMC 바로가기
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 PneumoniaArticle Published on 2022-10-012022-11-16 Journal: Lung [Category] COVID19(2023년), SARS, 변종, [키워드] adult subject ambient animal model ARDS better respiratory function blood gas analysis Comorbidities consolidation COVID-19 Delta described evidence of explain hospital Hospitalization Immunity in vitro Infection Inpatient Italy less Lineage Lower lower mortality lower risk lung parenchyma observation omicron other variant Pneumonia preliminary finding replication capacity respiratory airway Respiratory failure SARS-CoV-2 severe respiratory failure Turin variants of concern virulence wild type [DOI] 10.1007/s00408-022-00566-7 PMC 바로가기
Respiratory Drive, Dyspnea, and Silent Hypoxemia: A Physiological Review in the Context of COVID-19Review Published on 2022-10-012023-07-09 Journal: Respiratory care [Category] COVID19(2023년), [키워드] ARDS COVID-19 Dyspnea hypoxic ventilatory decline hypoxic ventilatory response silent hypoxia [DOI] 10.4187/respcare.10075 [Article Type] Review
A comprehensive review on current understanding of bradykinin in COVID-19 and inflammatory diseasesReview Published on 2022-10-012023-07-09 Journal: Molecular biology reports [Category] COVID19(2023년), [키워드] ARDS Bradykinin storm Inflammation Kinin receptors RAAS pathway vasodilator [DOI] 10.1007/s11033-022-07539-2 PMC 바로가기 [Article Type] Review
Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDSResearch article Published on 2022-10-012022-10-05 Journal: Journal of critical care [Category] 바이오마커, [키워드] Activation APACHE II ARDS Coagulation correlated COVID-19 COVID-19 patients Critically ill D-dimer D-dimer level determine discharge discharged enrolled help identify Increased Invasive mechanical ventilation less likelihood material measurement mechanical ventilation outcome outcomes P/F ratio Patient patients with COVID-19 performed Pneumonia primary endpoint Respiratory dead space Respiratory system Result static compliance subgroup of patient supported volumetric Volumetric capnography [DOI] 10.1016/j.jcrc.2022.154095 [Article Type] Research article
Effectiveness and safety of fibrinolytic therapy in critically ill patients with COVID-19 with ARDS: protocol for a prospective meta-analysisArticle Published on 2022-09-262022-11-16 Journal: BMJ Open [Category] meta-analysis, SARS, [키워드] acute respiratory distress anticoagulation ARDS bleeding disorder bleeding disorders & bleeding event clinical trial clinical trials Coagulopathies COVID-19 COVID-19 pandemic Critical care Critically ill patient Efficacy and safety eligibility criteria eligible Evidence fibrin deposit fibrinolytic FIVE Gas exchange identify IMPROVE include Intensive intensive & lung Meta-analysis microthrombi Mortality other organs outcome Oxygenation Patient patients patients with COVID-19 peer-reviewed performed PROSPERO protocol quantitative synthesis randomised controlled trial Registered Safety secondary outcome Standard of care syndrome therapy Trial ventilation/perfusion with COVID-19 [DOI] 10.1136/bmjopen-2022-063855 PMC 바로가기